Skip to main content
. 2021 Feb 3;41(5):972–980. doi: 10.1523/JNEUROSCI.2228-20.2020

Table 1.

Statistical analysis and the number of animals/samples used in the experiments

Graph Pre hoc Post hoc N, number of samples/animals per group
1A Three-way ANOVA (time × genotype × drug):
General effect:
Time (IOS): F(1,34) = 4.139, p = 0.0498*
Genotype: F(1,34) = 0.7739, p = 0.3852
chABC: F(1,34) = 5.164, p = 0.0295*
Interaction:
Time × genotype: F(1,34) = 4.861, p = 0.0343*
Time × chABC: F(1,34) = 6.483, p = 0.0156*
Genotype × chABC: F(1,34) = 7.244, p = 0.0110*
Time × genotype × chABC: F(1,34) = 5.899, p = 0.0206*
Tukey's multiple comparison test:
WT-chABC (IOS1) × WT-chABC (IOS2): p = 0.0002*
WT-vehicle: 3 (we have used the lowest number of animals possible in the control group to reduce the total number of animals used in the experiments; there is abundant evidence of no shift in ocular dominance in adult WT mice both from our lab and in the literature)
WT-chABC: 6
PV-TRKB+/−-vehicle: 5
PV-TRKB+/−-chABC: 7
1B Mann–Whitney: U = 0, p = 0.0286* Vehicle: 4
chABC: 4
1C Two-way ANOVA:
Interaction: F(1,20) = 3.921, p = 0.0616
BDNF: F(1,20) = 155.2, p < 0.0001*
Aggrecan: F(1,20) = 5.117, p = 0.035*
Tukey's multiple comparison test:
BDNF-vehicle × BDNF-aggrecan: p = 0.0329*
Vehicle-vehicle: 6
Vehicle-aggrecan: 6
Vehicle-BDNF: 6
BDNF-aggrecan: 6
2B Unpaired t test: T22 = 4384, p = 0.0002* WT: 12
PTPσ+/−: 12
2C One-way ANOVA:
F(2,14) = 91.44, p < 0.0001*
Tukey's multiple comparison test: WT × PTPσ+/−: p = 0.0007*
WT × PTPσ-/-: p < 0.0001*
PTPσ+/− × PTPσ-/-: p < 0.0001*
WT: 5
PTPσ+/−: 6
PTPσ-/-: 6
2D Mann–Whitney: U = 0, p = 0.0002* WT: 7
PTPσ+/−: 9
2E Mann–Whitney: U = 9, p = 0.0164* WT: 7
PTPσ+/−: 9
2F Two-way ANOVA:
Interaction: F(1,8) = 33,13, p = 0.0004*
Time: F(1,8) = 40.81, p = 0.0002*
Genotype: F(1,8) = 36.70, p = 0.0003*
Bonferroni's multiple comparison test:
IOS1-PTPσ+/− × IOS2- PTPσ+/−: p = 0.0001*
WT: 6
PTPσ+/−: 4
3A One-way ANOVA:
F(2,15) = 6.734, p = 0.0082*
Bonferroni's multiple comparison test:
vehicle × fluoxetine 1 μm: p = 0.0046*
Vehicle: 6
Fluoxetine 0.1 μm: 6
Fluoxetine 1 μm: 6
3B Unpaired t test: t(6) = 4.025, p = 0.0069* Vehicle: 4
Fluoxetine: 4
3C Unpaired t test: t(28) = 0.9872, p = 0.3320 Vehicle: 15
Fluoxetine: 15
3D Two-way ANOVA:
Interaction: F(1,19) = 0.8761, p = 0.3610
Fluoxetine: F(1,19) = 2.627, p = 0.1216
TRKB mutation: F(1,19) = 5.131, p = 0.0354*
WT-TRKB-vehicle: 6
WT-TRKB-fluoxetine: 6
Mutant TRKB-vehicle: 5
Mutant TRKB-fluoxetine: 6

*Statistically significant.

HHS Vulnerability Disclosure